A Safety Study of LY2811376 Single Doses in Healthy Subjects

NCT00838084 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: LY2811376
DRUG: Placebo

Sponsor

Eli Lilly and Company